Two-Dimensional Theranostic Nanomaterials in Cancer Treatment: State of the Art and Perspectives
Open Access
Abstract
As the combination of therapies enhances the performance of biocompatible materials in cancer treatment, theranostic therapies are attracting increasing attention rather than individual approaches. In this review, we describe a variety of two-dimensional (2D) theranostic nanomaterials and their efficacy in ablating tumors. Though many literature reports are available to demonstrate the potential application of 2D nanomaterials, we have reviewed here cancer-treating therapies based on such multifunctional nanomaterials abstracting the content from literature works which explain both the in vitro and in vivo level of applications. In addition, we have included a discussion about the future direction of 2D nanomaterials in the field of theranostic cancer treatment.Keywords
Funding Information
- National Research Foundation of Korea (2019R1A4A1024116 and 2019R1F1A1062216)
This publication has 130 references indexed in Scilit:
- Graphene oxide mediated delivery of methylene blue for combined photodynamic and photothermal therapyBiomaterials, 2013
- Photothermally Triggered Cytosolic Drug Delivery via Endosome Disruption Using a Functionalized Reduced Graphene OxideACS Nano, 2013
- Controlled Scalable Synthesis of Uniform, High-Quality Monolayer and Few-layer MoS2 FilmsScientific Reports, 2013
- Upconversion Nanoparticles for Photodynamic Therapy and Other Cancer TherapeuticsTheranostics, 2013
- Photoacoustic Tomography: In Vivo Imaging from Organelles to OrgansScience, 2012
- Manganese-based MRI contrast agents: past, present, and futureTetrahedron, 2011
- Responsive Theranostic Systems: Integration of Diagnostic Imaging Agents and Responsive Controlled Release Drug Delivery CarriersAccounts of Chemical Research, 2011
- Photodynamic therapy of cancer: An updateCA: A Cancer Journal for Clinicians, 2011
- PEGylated Nanographene Oxide for Delivery of Water-Insoluble Cancer DrugsJournal of the American Chemical Society, 2008
- Ligand-Directed Nanobialys as Theranostic Agent for Drug Delivery and Manganese-Based Magnetic Resonance Imaging of Vascular TargetsJournal of the American Chemical Society, 2008